| Structure | Cat No. | Product Name | CAS No. | Product Description |
|---|---|---|---|---|
|
V70304 | GPR119 agonist 2 | 1384951-03-4 | GPR119 agonist 2 (compound 43) is an orally bioactive GPR119 agonist. |
|
V70307 | GPR139 agonist-2 | 2983118-29-0 | GPR139 agonist-2 (compound 20a) is a potent GPR139 agonist/activator with EC50 of 24.7 nM. |
|
V75413 | GPR35 agonist 3 | 123021-85-2 | GPR35 agonist 3 is a synthetic GPR35 agonist/activator with EC50 of 1.4 μM. |
|
V75412 | GPR35 agonist 5 | 2226201-24-5 | GPR35 agonist 5 (3,5-dinitro-bisphenol A; compound 6) is a weak GPR35 agonist. |
|
V75411 | GPR4 antagonist 1 | 1197879-16-5 | GPR4 antagonist 1 is an antagonist of GPR4 with IC50 of 189 nM. |
|
V79955 | GPR55 agonist 3 | GPR55 agonist 3 (Compound 26) is a GPR55 agonist (EC50= 0.239 nM, 1.76 nM for hGPR55 and rGPR55, respectively). | |
|
V80068 | GPR55 agonist 4 | GPR55 agonist 4 (Compound 28) is a GPR55 agonist (EC50= 131 nM, 1.41 nM for hGPR55 and rGPR55). | |
|
V75406 | GPR81 agonist 2 | 1143024-28-5 | GPR81 agonist 2 (compound 1) is a potent GPR81 agonist/activator with EC50s of 0.023 and 0.123 µM for hGPR81 and hGPR109A respectively. |
|
V75420 | GPR84 antagonist 1 | 2762180-28-7 | GPR84 antagonist 1 is a high-affinity, selective competitive antagonist of human GPR84. |
|
V75418 | GPR84 antagonist 2 | 2244269-74-5 | GPR84 antagonist 2 (compound 33) is an orally bioactive, selective GPR84 antagonist (IC50=8.95 nM). |
|
V75421 | GPR84 antagonist 3 | 2815263-05-7 | GPR84 antagonist 3 (compound 42) is a potent GPR84 (G protein-coupled receptor 84) antagonist. |
|
V75423 | GPR88 agonist 2 | 2821859-71-4 | GPR88 agonist 2 (compound 53) is a potent, BBB (blood-brain barrier) permeable (penetrable) GPR88 agonist/activator with EC50 of 14 nM in GPR88 cAMP functional assays. |
|
V75422 | GPR88-IN-1 | 714265-50-6 | GPR88-IN-1 is a GPR88 inhibitor that may be utilized in the research/study of central diseases. |
|
V1804 | GSK1292263 | 1032823-75-8 | GSK1292263 is a novel and potentGPR119 (G-protein-coupled receptor 119) agonist whichhas potential for the treatment of type 2 diabetes. |
|
V1805 | GW9508 | 885101-89-3 | GW9508 is a novel, potent and selective agonist for FFA1 (fatty acid receptor GPR40) with pEC50 of 7.32, and is 100-fold selective against GPR120, it stimulates insulin secretion in a glucose-sensitive manner. |
|
V70560 | hMCH-1R antagonist 1 | 353487-64-6 | hMCH-1R antagonist 1 (Compound 30) is a potent and specific human melanin concentrating hormone receptor 1 (hMCHR1) antagonist (inhibitor) with a KB of 3.6 nM. |
|
V70310 | L-α-lysophosphatidylinositol (Soy) (sodium) | 796963-91-2 | L-α-lysophosphatidylinositol Soy sodium is the endogenous ligand of GPR55. |
|
V15704 | Latanoprost (PHXA41, XA34) | 130209-82-4 | Latanoprost (PHXA-41, XA-34) is a novel prostaglandinF2α analogue that lowers the pressure by increasing the outflow of aqueous fluid from the eyes through the uvealsclearal tract. |
|
V75414 | MS48107 | 2375070-79-2 | MS48107 is a potent and specific PAM (positive allosteric modulator) of G protein-coupled receptor 68 (GPR68). |
|
V75417 | Ogremorphin (OGM; GPR68-IN-1) | 352563-21-4 | Ogremorphin (GPR68-IN-1) is a potent GPR68 inhibitor (antagonist) with EC50 of 170 nM. |
Products are for research use only; We do not sell to patients
Copyright 2020 InvivoChem LLC | All Rights Reserved
